News &amp; Updates

Only 1 in 4 people feels fully recovered a year after hospitalization for COVID-19, according to a new study in the UK. That’s how long and severe COVID symptoms can be.

OMDI shows potential as first-line treatment for glaucoma in real-world trial

In a retrospective review of real-world data from Japan, omidenepag isopropyl 0.002% ophthalmic solution (OMDI) demonstrated an intraocular pressure (IOP)-lowering effect in eyes with different types of glaucoma, without severe or serious adverse effects.

24 May 2022

CIEDs give clues to time of patient death

Postmortem interrogation of cardiac implantable electrical devices (CIED) can help pinpoint a patient’s time of death, according to a recent study. While forensic analysis of explanted CIEDs is valid, accuracy of time determination varies across different devices.

Dextrose gel reduces need for intravenous fluids in babies with asymptomatic hypoglycaemia

In neonates who have asymptomatic hypoglycaemia in the first 48 hours of life, administering dextrose gel is useful and minimizes requirement for intravenous fluids, as shown in a study.

OPEN MY: Recognize obesity as disease, not lifestyle disorder

Obesity must be treated as a chronic disease, not just a self-inflicted lifestyle disorder, to effectively tackle the rising burden thereof, says an international advocacy group.

24 May 2022

Newborn screening facilitates timely detection, treatment of late-onset Pompe disease

In one-fifth of patients, late-onset Pompe disease (LOPD) manifests within 15 years of detection, a recent study has found. Newborn screening (NBS) can help detect LOPD early despite having no symptoms, and may lead to timely treatment administration.

Loneliness tied to pain-fatigue-depression cluster in older adults

High levels of loneliness among elderly adults increase the likelihood of reporting pain, fatigue, depression, and the cluster of all three symptoms, reports a recent study.

Fewer hospitalizations with omicron vs delta suggest reduced severity of omicron variant

23 May 2022 by

Infection with the omicron variant of SARS-CoV-2 was less likely to result in hospitalization than infection with the delta variant, according to an observational study from Denmark presented at ECCMID 2022 and published in The Lancet.

23 May 2022

‘1-2-3-4-day rule’: Initiating DOACs according to stroke severity may be the way to go

23 May 2022 by

Following nonvalvular atrial fibrillation (NVAF)-associated stroke events, a graded increase in delay in direct oral anticoagulants (DOACs) initiation of between 1 and 4 days, depending on the severity of the index event, appears to be effective for recurrent stroke prevention and does not compromise safety both in Asians and Europeans, according to a recent study.

Surgery plus radiotherapy no better than surgery alone in cutaneous squamous cell carcinoma

Poor outcomes are not significantly different in between patients with high-risk cutaneous squamous cell carcinomas treated with margin-negative resection only and those who underwent surgery with adjuvant radiotherapy, reveals a study.